Literature DB >> 15451336

Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.

Brooke Rossi1, Mitchell D Creinin, Leslie A Meyn.   

Abstract

We performed this analysis to evaluate the ability of both women and their clinicians to predict pregnancy expulsion after using mifepristone and misoprostol for medical abortion up to 63 days gestation. Women who participated in a multicenter, randomized trial comparing misoprostol 6-8 h vs. 23-25 h after mifepristone attended a follow-up visit approximately 7 days after mifepristone treatment. Each subject was asked if she felt she had expelled the gestational sac. Clinicians also assessed if the sac had been expelled based on the woman's history. Vaginal ultrasonography was then performed to assess the uterine cavity. Of the 1080 women enrolled in the multicenter study, 931 (86.2%) who attended the first follow-up visit by study day 12 and did not have a uterine suction aspiration prior to this visit were included in this analysis. Vaginal ultrasonography at the first follow-up visit demonstrated expulsion in 915 [98.3%, 95% confidence interval (CI): 97.2-99.0] women. Overall, sensitivity, specificity, and positive and negative predictive values for subjects were 96.5%, 31.3%, 98.8% and 13.5%, respectively. When both the clinician and patient felt that the gestational sac had passed (n = 880 [94.5%, 95% CI: 92.9-95.9]), expulsion was confirmed by sonography in 99.1% (95% CI: 98.2-99.6) of cases. Women and clinicians are very accurate at determining expulsion of gestational sac during medical abortion with mifepristone and misoprostol without ultrasonography or a physical examination. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451336     DOI: 10.1016/j.contraception.2004.04.005

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

1.  Progestin-based contraceptive on the same day as medical abortion.

Authors:  Jeanna Park; Nuriya Robinson; Ursula Wessels; James Turner; Stacie Geller
Journal:  Int J Gynaecol Obstet       Date:  2016-01-06       Impact factor: 3.561

2.  Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.

Authors:  Mette Løkeland; Ole Erik Iversen; Anders Engeland; Ingrid Økland; Line Bjørge
Journal:  Acta Obstet Gynecol Scand       Date:  2014-05-23       Impact factor: 3.636

Review 3.  A research agenda for moving early medical pregnancy termination over the counter.

Authors:  N Kapp; D Grossman; E Jackson; L Castleman; D Brahmi
Journal:  BJOG       Date:  2017-04-27       Impact factor: 6.531

4.  Determination of medical abortion success by women and community health volunteers in Nepal using a symptom checklist.

Authors:  Kathryn L Andersen; Mary Fjerstad; Indira Basnett; Shailes Neupane; Valerie Acre; Sharad Sharma; Emily Jackson
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-11       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.